Characterisation of an aptamer against the Runt domain of AML1 (RUNX1) by NMR and mutational analyses

Since the invention of systematic evolution of ligands by exponential enrichment, many short oligonucleotides (or aptamers) have been reported that can bind to a wide range of target molecules with high affinity and specificity. Previously, we reported an RNA aptamer that shows high affinity to the Runt domain (RD) of the AML1 protein, a transcription factor with roles in haematopoiesis and immune function. From kinetic and thermodynamic studies, it was suggested that the aptamer recognises a large surface area of the RD, using numerous weak interactions. In this study, we identified the secondary structure by nuclear magnetic resonance spectroscopy and performed a mutational study to reveal the residue critical for binding to the RD. It was suggested that the large contact area was formed by a DNA‐mimicking motif and a multibranched loop, which confers the high affinity and specificity of binding.

[1]  Yoshikazu Nakamura,et al.  Conjugation of two RNA aptamers improves binding affinity to AML1 Runt domain , 2017, Journal of biochemistry.

[2]  Gota Kawai,et al.  NMR monitoring of the SELEX process to confirm enrichment of structured RNA , 2017, Scientific Reports.

[3]  Yoshikazu Nakamura,et al.  Kinetic and Thermodynamic Analyses of Interaction between a High-Affinity RNA Aptamer and Its Target Protein. , 2016, Biochemistry.

[4]  John C. Burnett,et al.  High throughput sequencing analysis of RNA libraries reveals the influences of initial library and PCR methods on SELEX efficiency , 2016, Scientific Reports.

[5]  Abhishek Parashar,et al.  Aptamers in Therapeutics. , 2016, Journal of clinical and diagnostic research : JCDR.

[6]  P. Andreasen,et al.  Expected and unexpected features of protein‐binding RNA aptamers , 2016, Wiley interdisciplinary reviews. RNA.

[7]  N. Janjić,et al.  Embracing proteins: structural themes in aptamer-protein complexes. , 2016, Current opinion in structural biology.

[8]  T. Mészáros,et al.  Is less more? Lessons from aptamer selection strategies. , 2014, Journal of pharmaceutical and biomedical analysis.

[9]  Yoshikazu Nakamura,et al.  Solution structure of a DNA mimicking motif of an RNA aptamer against transcription factor AML1 Runt domain. , 2013, Journal of biochemistry.

[10]  Yoshikazu Nakamura,et al.  The Runt domain of AML1 (RUNX1) binds a sequence-conserved RNA motif that mimics a DNA element , 2013, RNA.

[11]  Yoshikazu Nakamura,et al.  RNA plasticity and selectivity applicable to therapeutics and novel biosensor development , 2012, Genes to cells : devoted to molecular & cellular mechanisms.

[12]  H. Schwalbe,et al.  High-resolution NMR structure of an RNA model system: the 14-mer cUUCGg tetraloop hairpin RNA , 2009, Nucleic acids research.

[13]  Stuart E. Knowling,et al.  Characterization of RNA aptamers that disrupt the RUNX1–CBFβ/DNA complex , 2009, Nucleic Acids Research.

[14]  D. Littman,et al.  RUNX proteins in transcription factor networks that regulate T-cell lineage choice , 2009, Nature Reviews Immunology.

[15]  S. Butcher,et al.  DNA mimicry by a high-affinity anti-NF-κB RNA aptamer , 2007, Nucleic acids research.

[16]  R. Stoltenburg,et al.  SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands. , 2007, Biomolecular engineering.

[17]  B. Sullenger,et al.  Gene therapy progress and prospects: RNA aptamers , 2007, Gene Therapy.

[18]  F. Mikhail,et al.  Normal and transforming functions of RUNX1: A perspective , 2006, Journal of cellular physiology.

[19]  N. Speck,et al.  Core-binding factors in hematopoiesis and immune function , 2004, Oncogene.

[20]  G. Ghosh,et al.  Molecular mimicry of the NF-κB DNA target site by a selected RNA aptamer , 2004 .

[21]  Jeff Zimmerman,et al.  Crystal structure of NF-κB (p50)2 complexed to a high-affinity RNA aptamer , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  U. Sauer,et al.  The RUNX1 Runt domain at 1.25A resolution: a structural switch and specifically bound chloride ions modulate DNA binding. , 2002, Journal of molecular biology.

[23]  N. Speck Core binding factor and its role in normal hematopoietic development. , 2001, Current opinion in hematology.

[24]  Jerónimo Bravo,et al.  The leukemia-associated AML1 (Runx1)–CBFβ complex functions as a DNA-induced molecular clamp , 2001, Nature Structural Biology.

[25]  Takashi Kumasaka,et al.  Structural Analyses of DNA Recognition by the AML1/Runx-1 Runt Domain and Its Allosteric Control by CBFβ , 2001, Cell.

[26]  B. Chait,et al.  Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain , 2000, Nature Structural Biology.

[27]  S. Minucci,et al.  Aberrant Recruitment of the Nuclear Receptor Corepressor-Histone Deacetylase Complex by the Acute Myeloid Leukemia Fusion Partner ETO , 1998, Molecular and Cellular Biology.

[28]  G. Varani,et al.  Structure of the P1 helix from group I self-splicing introns. , 1995, Journal of molecular biology.

[29]  H. Wolfson,et al.  Shape complementarity at protein–protein interfaces , 1994, Biopolymers.

[30]  M. Lawrence,et al.  Shape complementarity at protein/protein interfaces. , 1993, Journal of molecular biology.

[31]  M. Ohki,et al.  t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[33]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[34]  L. Kay,et al.  Comparison of different modes of two-dimensional reverse-correlation NMR for the study of proteins , 1990 .

[35]  Pierre Plateau,et al.  Exchangeable proton NMR without base-line distorsion, using new strong-pulse sequences , 1982 .

[36]  M. Ohki,et al.  t ( 8 ; 21 ) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene , AMLJ ( chromosomal translocation / cancer genetics , 2022 .